An inconsistency in TSHR expression data for FTC-133 cell lines derived from lymph node metastases of differentiated follicular thyroid carcinoma across different laboratories has been noted, which may be attributable to genetic drift or epigenetic changes occurring during cell line passaging (77, 78). The gene discussed is TSHR; the disease is thyroid gland follicular carcinoma.